Ocular Inflammation in Solid Organ Transplant Patients Receiving Maintenance Immunosuppression

PURPOSE: Patients are maintained on lifelong immunomodulatory therapy (IMT) after organ transplantation; however, new inflammatory conditions have developed in transplant recipients despite systemic immunosuppression. A prior study reported uveitis in transplant patients on IMT but did not describe clinical courses. We report the first case series describing nine cases of presumed non-infectious uveitis/scleritis in transplant recipients on IMT. METHODS: Patients with a history of a solid organ transplantation who were diagnosed with uveitis and/or scleritis from June 2014 to June 2026 were identified. Inclusion required transplantation prior to uveitis/scleritis occurrence and ongoing IMT. Cases with a history of uveitis/scleritis prior to transplant, trauma/surgery, infection, or a history of autoimmune conditions causing uveitis were excluded. Nine cases met the criteria, and clinical characteristics-including transplant history and ocular disease course-were abstracted. RESULTS: = 2) transplants, were included. The mean age was 46.9 years; patients developed uveitis or scleritis a median of 4 years after the most recent transplant. All patients were treated with topical or oral corticosteroids at a minimum. Six patients had a single episode of ocular inflammation, and three patients had recurrences. All episodes were corticosteroid responsive. CONCLUSION: This case series describes presumed non-infectious ocular inflammation in solid organ transplant recipients receiving IMT, supporting a possibility of a broader pattern of post-transplant immune dysregulation. While patients in this series had steroid-responsive ocular inflammation, this phenomenon warrants further investigation to clarify mechanisms underlying new inflammation despite systemic immunosuppression, particularly because IMT agents are often employed in treating chronic uveitis.

Authors

Institutions

Publication Details

Journal
Ocular Immunology and Inflammation
Published
2026-11-12
DOI
https://doi.org/10.1080/09273948.2026.2751588
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ocular Inflammation in Solid Organ Transplant Patients Receiving Maintenance Immunosuppression

Kavya P. Katragadda, Alan Gary Palestine, Amit K. Reddy, Jessica A. Kraker et al.
Ocular Immunology and Inflammation
Ocular Diseases and Behçet’s Syndrome
article

Ocular Inflammation in Solid Organ Transplant Patients Receiving Maintenance Immunosuppression

Kavya P. Katragadda, Alan Gary Palestine, Amit K. Reddy, Jessica A. Kraker, Lynn Marisa Hassman
article en

Abstract

PURPOSE: Patients are maintained on lifelong immunomodulatory therapy (IMT) after organ transplantation; however, new inflammatory conditions have developed in transplant recipients despite systemic immunosuppression. A prior study reported uveitis in transplant patients on IMT but did not describe clinical courses. We report the first case series describing nine cases of presumed non-infectious uveitis/scleritis in transplant recipients on IMT. METHODS: Patients with a history of a solid organ transplantation who were diagnosed with uveitis and/or scleritis from June 2014 to June 2026 were identified. Inclusion required transplantation prior to uveitis/scleritis occurrence and ongoing IMT. Cases with a history of uveitis/scleritis prior to transplant, trauma/surgery, infection, or a history of autoimmune conditions causing uveitis were excluded. Nine cases met the criteria, and clinical characteristics-including transplant history and ocular disease course-were abstracted. RESULTS: = 2) transplants, were included. The mean age was 46.9 years; patients developed uveitis or scleritis a median of 4 years after the most recent transplant. All patients were treated with topical or oral corticosteroids at a minimum. Six patients had a single episode of ocular inflammation, and three patients had recurrences. All episodes were corticosteroid responsive. CONCLUSION: This case series describes presumed non-infectious ocular inflammation in solid organ transplant recipients receiving IMT, supporting a possibility of a broader pattern of post-transplant immune dysregulation. While patients in this series had steroid-responsive ocular inflammation, this phenomenon warrants further investigation to clarify mechanisms underlying new inflammation despite systemic immunosuppression, particularly because IMT agents are often employed in treating chronic uveitis.

Ocular Immunology and Inflammation
University of Colorado Anschutz Medical Campus (US)
Good health and well-being
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon